Notably, Atacicept, an IgG1 Fc region fusion protein that binds BAFF and a proliferation-inducing ligand (APRIL) resulted in higher rates of MS relapse and conversion to MS in clinical trials (70, 71). Here, TNFSF13 is linked to myeloid sarcoma.